Loading
Distinct shells carrying a filed role for this person — not every shell they have ever touched.
SEC-verified vehicles of the same sponsor, predating these roles and carrying none of them. The badge counts them; the figure beside this one does not.
Mergers closed across all 8 — these vehicles and the franchise's earlier ones together.
Announced but not closed, and still hunting — again over all 8.
No closed vehicle here has both a stored price and a filed trust value to score it against.
1 liquidated · 1 terminated deal — weigh against the wins.
3 vehicles on file, newest listing first
none appears on more than one · 2 vehicles carry no counterparty filing we have read
2 people on two or more of them
SPAC veteran and former head of corporate strategy at Hudson Capital.
Dr. Suying Liu is a seasoned SPAC sponsor and financial executive who currently serves as Chairman, Chief Executive Officer, and Chief Financial Officer of Mountain Crest Acquisition 6 Corp. (Nasdaq: MCAH), a role he assumed effective January 6, 2026. In this capacity he consolidates all principal executive, financial, and accounting authority, overseeing target sourcing, deal negotiation, and business combination strategy for the blank check company, which raised $60 million in its IPO and targets businesses in North America and the Asia Pacific region. He also controls Mountain Crest Holdings 6 LLC, the sponsor entity behind the SPAC, and may be deemed to share beneficial ownership of the securities held directly by that vehicle. His estimated net worth, derived from SEC filings, is reported in the range of $29 million to over $100 million, with approximately 3.0 million shares of MCAH stock and significant holdings across the broader Mountain Crest SPAC family.
Dr. Liu founded Mountain Crest Acquisition Corp. in 2019 and served as its Chairman and Chief Executive Officer through 2021, leading the firm's first SPAC (Nasdaq: MCAC) to a business combination with Playboy Enterprises (PLBY) in a deal valued at approximately $381 million. He subsequently sponsored and led a prolific series of additional blank check vehicles: Mountain Crest Acquisition Corp. II (Nasdaq: MCAD), which IPO'd in December 2020 and closed a $150 million merger with Better Therapeutics (BTTX); Mountain Crest Acquisition Corp. III (Nasdaq: MCAE), which IPO'd in April 2021 and completed a $1.0 billion healthcare-sector merger with ETAO Group; Mountain Crest Acquisition Corp
[Origin not recorded. Carried over from /people/liu-suying-1534, a second record for the same person.]
This record is keyed to SEC CIK 0001811534 — the identifier this person files under in their own name. Every vehicle above is a filing made under that CIK, so “the same person on two shells” is a fact about an SEC identifier rather than about a name that happens to match.
Roles are the strings the filings used, in the order they were filed. Nothing on this page ranks them, infers seniority, or offers a reason why any two of these names recur — a recurrence is a count, and the filings that produced it are linked beside every row. We also hold 65 institutional-holder rows on these vehicles, under 26 distinct name strings, and none of them is counted across vehicles: that table has no CIK column, and matching holders by name would merge firms that are not the same firm.